P/E at 58.15 vs Industry's 55.37: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Amidst Sector Norms

The current P/E of 58.15 for Apollo Hospitals Enterprise Ltd. stands approximately 5.1% above the hospital sector’s average P/E of 55.37. This premium suggests that investors are willing to pay a slightly higher multiple for the company’s earnings relative to its peers. Such a valuation can reflect expectations of superior earnings growth, brand strength, or operational resilience. However, the premium is not excessive, indicating a balanced market view rather than exuberance. Apollo Hospitals Enterprise Ltd.’s market capitalisation of ₹1,03,890.88 crores places it firmly in the large-cap category within the hospital sector, reinforcing its stature as a key player.

Performance Across Timeframes: Divergent Momentum

Examining returns across multiple timeframes reveals a complex performance profile. Over the past year, the stock has delivered a positive return of 8.98%, outperforming the Sensex which declined by 4.89% during the same period. This outperformance extends to longer horizons, with three-year and five-year returns of 69.17% and 145.24% respectively, significantly ahead of the Sensex’s 26.28% and 46.14%. Even the ten-year return of 420.42% dwarfs the Sensex’s 188.69%, underscoring the company’s long-term growth trajectory.

However, shorter-term returns tell a different story. The stock’s one-month performance is down 6.08%, though this is less severe than the Sensex’s 12.18% decline. Over the past week, the stock has fallen 3.57%, slightly worse than the Sensex’s 3.12% drop. Notably, the three-month return is positive at 2.14%, contrasting with the Sensex’s 14.47% decline. This divergence suggests that while the broader market has struggled recently, Apollo Hospitals Enterprise Ltd. has shown relative resilience. The 2-day consecutive gain and a 2.06% rise in that period further highlight short bursts of positive momentum — but is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Moving Average Configuration: Mixed Technical Signals

The technical picture for Apollo Hospitals Enterprise Ltd. is nuanced. The stock currently trades above its 50-day and 100-day moving averages, signalling some medium-term strength. However, it remains below the 5-day, 20-day, and 200-day moving averages, indicating short-term weakness and a longer-term resistance level yet to be breached. This configuration often points to a stock in a consolidation phase or a tentative recovery within a broader downtrend. The 200-day moving average, a key indicator of long-term trend, remains a hurdle for sustained bullish momentum.

Sector Performance Context

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances among constituent stocks. Apollo Hospitals Enterprise Ltd.’s relative outperformance over the past year and resilience in the three-month window suggest it is among the more robust names in the sector. This relative strength may reflect the company’s diversified operations, brand equity, and scale advantages. Yet, the sector’s overall volatility and the stock’s short-term dips highlight ongoing challenges in the healthcare space.

Rating Reassessment: Previously Rated Buy

Apollo Hospitals Enterprise Ltd. was previously rated Buy by MarketsMOJO, with a Mojo Score of 55.0. The rating was updated on 09 Jan 2026, reflecting a reassessment of the company’s fundamentals and market conditions. While the current rating is not disclosed, the change signals a shift in the evaluation of the stock’s risk-reward profile. The stock’s recent price action, valuation premium, and mixed technical signals likely contributed to this reassessment — previously rated Buy, what is Apollo Hospitals Enterprise Ltd.’s current rating?

Comparative Performance vs Sensex

Across multiple timeframes, Apollo Hospitals Enterprise Ltd. has consistently outperformed the Sensex. The one-year gain of 8.98% contrasts with the Sensex’s 4.89% loss, while the three-month positive return of 2.14% stands out against the Sensex’s 14.47% decline. Even the year-to-date return of 2.60% beats the Sensex’s 14.17% drop. This relative strength underscores the stock’s defensive qualities within a volatile market environment. However, the recent one-week and one-month declines, though less severe than the Sensex’s, indicate some short-term pressure.

Market Capitalisation and Industry Standing

With a market capitalisation exceeding ₹1,03,890 crores, Apollo Hospitals Enterprise Ltd. is a dominant large-cap within the hospital sector. Its scale provides competitive advantages in terms of network reach, brand recognition, and operational efficiencies. The hospital industry itself is characterised by a mix of growth and regulatory challenges, making valuation premiums like Apollo’s a reflection of perceived stability and growth potential. Should investors in Apollo Hospitals Enterprise Ltd. hold, buy more, or reconsider?

Conclusion: A Balanced Valuation and Mixed Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector, with a strong long-term performance record and recent mixed momentum. The valuation premium of approximately 5% over the industry average suggests cautious optimism from the market, while the moving average configuration indicates a stock in consolidation with potential for recovery if it can surpass key resistance levels. The rating reassessment from Buy to Hold by MarketsMOJO on 09 Jan 2026 reflects these nuanced factors. Investors may wish to consider how the stock’s short-term dips and technical signals align with their portfolio objectives — what is the current rating for Apollo Hospitals Enterprise Ltd. and how should it influence investment decisions?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today